Varex Q3 FY2026 Results Show Revenue Growth and Margin Expansion Ahead of Teledyne Transaction
Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue of $211 million, up 4% year over year, with Industrial revenue at $77 million and Medical at $134 million. Non-GAAP gross margin rose to 37% from 34% and non-GAAP EPS increased to $0.31 from $0.13. Tariff refunds and customer reimbursements added about $10 million to gross profit. Varex cancelled its earnings call and declined guidance due to a pending Teledyne Technologies transaction.
How this was made
The 30-second read
Why it matters
The quarter shows revenue growth and higher non-GAAP margins and EPS, but the company explicitly flags tariff-related profitability support and reduced forward visibility due to the pending Teledyne transaction.
Market read
Traders can reassess earnings quality (tariff-driven gross profit uplift) and deal-related uncertainty (no guidance, cancelled call) while monitoring whether industrial growth and margins hold without the tariff benefit.
What to watch
Cash and marketable securities fell to $99M from $155M, and the company is withholding guidance while the Teledyne transaction is pending, which can raise deal-timing and execution risk for valuation.
Background
Varex Imaging released Q3 FY2026 results and highlighted that IEEPA tariff refunds and related customer reimbursements added about $10M to quarterly gross profit.
Ticker impact
Varex reported Q3 FY2026 revenue of $211M (+4% YoY) and non-GAAP gross margin expansion to 37% from 34%, while noting a ~$10M tariff-refund benefit.
Near-term sentiment likely positive on margin expansion, but traders may discount earnings quality given the tariff-related gross profit uplift and focus on Teledyne deal progression.
The article provides specific quarterly financial metrics (revenue, margins, EPS, operating cash flow) and quantifies the tariff-related gross profit benefit (~$10M), plus a deal-related procedural change (cancelled earnings call, no guidance) that can increase uncertainty.
Market effects
Improving margins in industrial and medical imaging demand could support sentiment toward imaging/inspection equipment peers, though tariff refund dynamics may be idiosyncratic.
No explicit regional macro linkage beyond U.S. Customs IEEPA tariff refunds.
Tariff and reimbursement mechanics are U.S.-policy linked, which can influence cross-border supply chain expectations for imaging components.
Counterpoint
Margin expansion may not persist if the ~$10M tariff-refund benefit fades, so the underlying operating trajectory could be weaker than headline non-GAAP metrics suggest.
Key entities
- companyVarex Imaging
Reported Q3 FY2026 revenue $211M (+4% YoY), non-GAAP gross margin 37% (up from 34%), non-GAAP EPS $0.31, and noted ~$10M tariff-related gross profit benefit; cancelled earnings call and declined guidance while Teledyne transaction is pending.
- companyTeledyne Technologies
Pending transaction is described as central to Varex investor considerations, prompting cancellation of the scheduled earnings call and no financial guidance.
- regulatorU.S. Customs (IEEPA tariff refunds)
Refunds from U.S. Customs for previously paid IEEPA tariffs were cited as contributing $17M in refunds, with $7M revenue reduction for expected customer reimbursements.
